Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

Clinical trial NCT07052578 · RECRUITING

Trial details

NCT number: NCT07052578
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2025-06-30
Primary completion: 2028-11-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.